Sinopharm - 2 Doses (2nd in 3 weeks)

Service Description

Who should be vaccinated first? While COVID-19 vaccine supplies are limited, health workers at high risk of exposure and older people should be prioritised for vaccination. Countries can refer to the WHO Prioritization Roadmap and the WHO Values Framework as guidance for their prioritisation of target groups. The vaccine is not recommended for persons younger than 18 years of age, pending the results of further studied in that age group. Should pregnant women be vaccinated? The available data on the Sinovac-CoronaVac (COVID-19) vaccine in pregnant women are insufficient to assess either vaccine efficacy or possible vaccine-associated risks in pregnancy. However, this vaccine is an inactivated vaccine with an adjuvant that is commonly used in many other vaccines with a well-documented safety profile, such as Hepatitis B and Tetanus vaccines, including in pregnant women. The effectiveness of the Sinovac-CoronaVac (COVID-19) vaccine in pregnant women is therefore expected to be comparable to that observed in non-pregnant women of similar age. Further studies are expected to evaluate safety and immunogenicity in pregnant women. Who else can take the vaccine? Vaccination is recommended for persons with comorbidities that have been identified as increasing the risk of severe COVID-19, including obesity, cardiovascular disease and respiratory disease.The vaccine can be offered to people who have had COVID-19 in the past. Available data shows that symptomatic reinfection is unlikely in these persons for up to 6 months after natural infection. Consequently, they may choose to delay vaccination to nearer the end of this period, especially when vaccine supply is limited. In settings where variants of concerns with evidence of immune escape are circulating earlier immunization after infection may be advisable. Vaccine effectiveness is expected to be similar in lactating women as in other adults. WHO recommends the use of the COVID-19 vaccine Sinovac-CoronaVac in lactating women as in other adults. WHO does not recommend discontinuing breastfeeding after vaccination. Who is the vaccine not recommended for? Individuals with a history of anaphylaxis to any component of the vaccine should not take it. Persons with acute PCR-confirmed COVID-19 should not be vaccinated until after they have recovered from acute illness and the criteria for ending isolation have been met. Anyone with a body temperature over 38.5°C should postpone vaccination until no fever